BioAmber Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 85

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 15

  • Investments
  • 5

BioAmber General Information

Description

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints, food additives and personal care products. BioAmber produces bio-succinic acid at a facility in Sarnia, Ontario, pursuant to a joint venture agreement with Mitsui. Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

Contact Information

Formerly Known As
DNP Green Technology
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Industrial Chemicals
Acquirer
Corporate Office
  • 1250 René-Lévesque Boulevard West
  • Suite 4310
  • Montreal, Quebec H3B 4W8
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAmber Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioAmber‘s full profile, request access.

Request a free trial

BioAmber Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology
Industrial Chemicals
Montreal, Canada
85 As of 2017
00000
000000&0

000000

nsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000000000000
Abingdon, United Kingdom
00 As of 0000
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioAmber Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocleave Venture Capital-Backed Abingdon, United Kingdom 00 00.000 0000000000 0 00.000
You’re viewing 1 of 1 competitors. Get the full list »

BioAmber Patents

BioAmber Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018526969-A Biobased production of functionalized alpha-substituted acrylates and c4 dicarboxylates Pending 04-Jun-2015 000000000
CA-2985231-A1 Biobased production of functionalized alpha-substituted acrylates and c4-dicarboxylates Inactive 04-Jun-2015 000000000
JP-2017520621-A Organic acids from homocitric acid and homocitric acid derivatives Pending 10-Jun-2014 000000000
US-20170113993-A1 Organic acids from homocitrate and homocitrate derivatives Inactive 10-Jun-2014 000000000
EP-3155113-A2 Organic acids from homocitrate and homocitrate derivatives Inactive 10-Jun-2014 C07C51/31
To view BioAmber’s complete patent history, request access »

BioAmber Executive Team (14)

Name Title Board Seat Contact Info
Fabrice Orecchioni President, Acting Chief Executive Officer & Chief Operating Officer
Michael Hartmann Executive Vice President
You’re viewing 2 of 14 executive team members. Get the full list »

BioAmber Board Members (12)

Name Representing Role Since
00000 00000000 BioAmber Board Member 000 0000
0000 000000 BioAmber Board Member 000 0000
0000 00000 Self Board Member 000 0000
You’re viewing 3 of 12 board members. Get the full list »

BioAmber Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioAmber Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioAmber‘s full profile, request access.

Request a free trial

BioAmber Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bioamber Sarnia 01-Aug-2017 000000000 Industrial Chemicals 0000000 0
Succinic Acid Production (BioAmber and CJ CheilJedang) 01-Jul-2017 00000 0000 Specialty Chemicals 0000-0000
Comet Bio 25-Feb-2015 00000 0000 Other Materials 0000-0000
Sinoven Biopolymers 04-Feb-2010 0000000000 Other Commercial Products
Bioamber Sarnia 01-Jan-2010 Joint Venture Industrial Chemicals 0000000 0
To view BioAmber’s complete investments and acquisitions history, request access »

BioAmber Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Comet Bio 25-Feb-2015 00000 00000 00 Completed
  • 2 buyers
To view BioAmber’s complete exits history, request access »

BioAmber FAQs

  • When was BioAmber founded?

    BioAmber was founded in 2008.

  • Where is BioAmber headquartered?

    BioAmber is headquartered in Montreal, Canada.

  • What is the size of BioAmber?

    BioAmber has 85 total employees.

  • What industry is BioAmber in?

    BioAmber’s primary industry is Industrial Chemicals.

  • Is BioAmber a private or public company?

    BioAmber is a Private company.

  • What is BioAmber’s current revenue?

    The current revenue for BioAmber is 00000.

  • How much funding has BioAmber raised over time?

    BioAmber has raised $282M.

  • Who are BioAmber’s investors?

    AquaRIMCO, Avrio Capital, Bioindustrial Innovation Canada, Export Development Canada, and LANXESS Deutschland are 5 of 13 investors who have invested in BioAmber.

  • Who are BioAmber’s competitors?

    Biocleave is a competitor of BioAmber.

  • When was BioAmber acquired?

    BioAmber was acquired on 01-Nov-2018.

  • Who acquired BioAmber?

    BioAmber was acquired by LCY Chemical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »